• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Donate Now
  • Sign up for CMA’s weekly newsletter!

Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

  • Eligibility/Enrollment
  • Coverage/Appeals
    • Medicare Costs
    • Self Help Materials – Toolkits & More
  • Topics
    • Basic Introduction to Medicare
    • Medicare Costs
    • Home Health Care
    • Improvement Standard and Jimmo News
    • Nursing Home / Skilled Nursing Facility Care
    • Outpatient Observation Status
    • Part B
    • Part D / Prescription Drug Benefits
    • Medicare for People Under 65
    • Medicare “Reform”
    • All Other Topics
    • Resources
      • Infographics
  • Publications
    • CMA Alerts
    • Fact Sheets & Issue Briefs
    • Infographics
    • The Medicare Handbook
    • SNF Enforcement Newsletter
    • Elder Justice Newsletter
    • Medicare Facts & Fiction
    • Articles by Topic
  • Litigation
    • Litigation News
    • Cases
    • Litigation Archive
    • Amicus Curiae Activities
  • Newsroom
    • Press Releases
    • Editorials & Letters to the Editor
    • CMA Comments, Responses, and Letters
    • CMA in the News
  • About Us
    • National Voices of Medicare Summit
    • Mission Statement
    • CMA FAQs
    • CMA Annual Impact Report
    • Personnel & Boards
    • The Center for Medicare Advocacy Founder’s Circle
    • Connecticut Dually Eligible Appeals Project
    • Community Outreach and Education Project (COEP)
    • National Medicare Advocates Alliance
    • CMA Webinars
    • Products & Services
    • Testimonials
    • Career, Fellowship & Internship Opportunities
    • Contact Us
  • Support Our Work
    • Donate Now
    • Build a Legacy with CMA
    • Join the Center for Medicare Advocacy Founder’s Circle
    • Take Action
    • Share Your Health Care Story
    • Tell Congress to Protect Our Care
    • Listen to Medicare & Health Care Stories
    • Sign up for CMA’s weekly newsletter!

Husband Reimbursed for Dying Wife’s Medication After Trying to Appeal Hospice Denial for Nearly Eight Years

November 18, 2015

Print Friendly, PDF & Email

When Emily Back was dying in early 2008, her treating physician prescribed a medication to help relieve her excruciating pain.  After the hospice provider refused to furnish the medication, her husband, in desperation, purchased it from the pharmacy, spending almost $6,000 of their own funds.  Mr. Back thought there must be some way to appeal the hospice’s denial of the drug, but he hit a wall at every turn, even with assistance from the Center for Medicare Advocacy.  Now, after nearly eight years, he has finally received a Medicare decision saying that the drug should have been covered.  His experience has nonetheless convinced him that “there is no working appeals process for Medicare hospice claims.”

The hospice provider told Mr. Back that he needed to file a claim with the Medicare contractor.  However, each time he tried to do so, the contractor repeatedly insisted that it could not process his claim without court documents naming him as the executor of his wife’s estate.  This should not have been an impediment to bringing a claim.  Many Medicare beneficiaries like Emily Back die without an estate, and therefore, without needing a court to appoint an executor.  By regulation, a person like Mr. Back who purchases healthcare items and services for a beneficiary is entitled to file a claim for Medicare payment on his own behalf.

Ultimately, though, Mr. Back’s claim never proceeded because the Centers for Medicare & Medicaid Services (CMS) informed him that only the hospice could submit a claim after furnishing the service or item.  At that point, Mr. Back sued the Secretary of the Department of Health and Human Services alleging that there was no administrative process for him to challenge the hospice provider’s refusal to furnish a necessary drug.  Ironically, the district court refused to assume jurisdiction over the suit on the grounds that Mr. Back had not exhausted his administrative remedies.

When Mr. Back next appealed to the United States Court of Appeals for the Ninth Circuit, the Secretary professed for the very first time that a hospice appeals process did exist, but that Mr. Back had not been given correct information about how to access it.  Accepting the Secretary’s allegation as true, the Court declared the case moot and advised Mr. Back to avail himself of the purported procedure.

At this point, four years had passed.  Mr. Back embarked again, this time utilizing Form 1490S, which the government mentioned was the correct approach to appeals.  The curious thing about Form 1490S is that it is a Medicare Part B claims form, whereas hospice care is a Medicare Part A benefit.  For over another year, Mr. Back encountered the same problem; the contractor repeatedly refused to process his claim for reimbursement without proof that he was the executor of his wife’s estate. 

When the contractor finally issued a decision denying coverage, it incorrectly analyzed the claim as one for drug coverage under Part B.  This is not surprising, since the appeal was filed on a Part B form and went to a Part B contractor.  Hospice was not even mentioned in the decision.  Mr. Back raised this point at the next two levels of review, but each decision-maker proceeded to analyze the claim under Part B standards – standards that do not apply to hospice coverage.  It was not until October 2015 that he received a decision from the Medicare Appeals Council (“MAC”) reflecting a proper understanding that his wife had been certified as terminally ill, had elected the hospice benefit, and was entitled to receive medication necessary for the palliation or management of her terminal illness and related conditions.

Mr. Back, who was 80 years old when his wife Emily died, is now 88.  He does not consider his MAC decision a victory.  His Kafkaesque experience confirms that the current mechanism for appealing a hospice denial is fundamentally flawed and in need of reform.  By his assessment, “Emily and I were fortunate in that we had the funds to go outside the system for the prescriptions….  many others would not be able to.”

When Medicare patients elect to receive hospice care, the law requires that “virtually all” care related to their terminal illness be furnished through or by the designated hospice provider.  This fact underscores the need for a contemporaneous appeals process that allows patients to request an expedited (within 24 – 48 hours) review and an appealable written decision whenever hospice providers refuse necessary care or are not providing enough care.  Mr. Back continues his pursuit to make this process a reality for hospice patients and their loved ones, and hopes that it may one day be known as an “Emily Appeal”.

For a timeline of the Back appeal, see http://www.MedicareAdvocacy.org/emily-back-hospice-appeal-fact-sheetchronology/.

The Center is interested in hearing from Medicare beneficiaries or their loved ones who have experienced problems in appealing the denial of items or services by a hospice agency.  Please contact us at hospice@MedicareAdvocacy.org.

November 18, 2015 – W. Kwok

Filed Under: Article Tagged With: Hospice, story

Primary Sidebar

Easy Access to Understanding Medicare

The Center for Medicare Advocacy produces a range of informative materials on Medicare-related topics.
Sign Up for CMA's Free Newsletter
Register for CMA's Free Webinars

  • Medicare Basics
  • Medicare Reform
  • CMA Alerts
  • Fact Sheets & Issue Briefs
  • CMA Webinars
  • Connecticut Info & Projects
  • Health Care Stories
  • Se habla Español

Jimmo v. Sebelius

Medicare covers skilled care to maintain or slow decline as well as to improve.

Improvement Isn’t Required. It’s the law!

Read more.

National Voices of Medicare Summit

With the many threats currently facing the Medicare program, now is the time to come together as allies and explore ways to advocate for comprehensive Medicare coverage, health equity, and quality health care. Drawing inspiration from real-life experiences and stories of beneficiaries and caregivers, we hope to share impactful discussions with you.

Learn more.

Center for Medicare Advocacy Follow 10,542 5,336

A national nonpartisan, nonprofit law organization working to advance access to comprehensive #Medicare coverage and quality #healthcare.

CMAorg
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
10h 2032514309784220116

AI to fight Medicare fraud?

CMS is proposing new “CRUSH” rules using analytics and AI to flag suspicious claims.

But David Lipschutz of the Center for Medicare Advocacy warns medically necessary care could be caught in the crossfire.

More audits. More scrutiny. What does that

Reply on Twitter 2032514309784220116 Retweet on Twitter 2032514309784220116 1 Like on Twitter 2032514309784220116 1 X 2032514309784220116
Retweet on Twitter Center for Medicare Advocacy Retweeted
matthewherper avatar Matthew Herper @matthewherper ·
13h 2032465053262196859

You can buy tickets to attend the STAT Breakthrough Summit East at this link:

Image for twitter card

STAT Summit East

agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now

www.statnews.com

Reply on Twitter 2032465053262196859 Retweet on Twitter 2032465053262196859 1 Like on Twitter 2032465053262196859 2 X 2032465053262196859
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
12 Mar 2032166580935647730

Some retirees are being automatically enrolled into Medicare Advantage plans by former employers or unions — even if they didn’t actively choose the plan.

Our new issue brief examines how this happens and why it raises concerns about beneficiary choice.

Stay informed on

Reply on Twitter 2032166580935647730 Retweet on Twitter 2032166580935647730 1 Like on Twitter 2032166580935647730 1 X 2032166580935647730
Retweet on Twitter Center for Medicare Advocacy Retweeted
alsadvocacy avatar ALS Advocacy @alsadvocacy ·
11 Mar 2031652436721492445

How do we get access to the "leading ALS scientific conference?"

Image for twitter card

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focu...

www.prnewswire.com

Reply on Twitter 2031652436721492445 Retweet on Twitter 2031652436721492445 1 Like on Twitter 2031652436721492445 2 X 2031652436721492445
Load More

Footer

Stay Connected:

  • Contact Us
  • Sitemap
  • Products & Services
  • Copyright/Privacy

© 2026 · Center for Medicare Advocacy